Skip to content
OpenCapital
Earnings
Screener
Charts
Portfolio
Pricing
Connect your AI
Get started
Toggle navigation menu
Stocks
Halozyme Therapeutics
Business Segments
Geographic
Total revenues
Total revenues
Halozyme Therapeutics
·
Geographic
·
1 segment
·
Rolls up to
Total Revenue
Breakdown
Segments
Geographic
View metric
Annual
Segment
FY'21
FY'22
FY'23
FY'24
FY'25
Geographic
$3.97M
$5.26M
$19.58M
$9.53M
$33.33M
Total
$443.31M
$660.12M
$829.25M
$1.02B
$1.4B
All segment values are derived from annual filings.